Table 2.
Characteristics of the Pooled Population From the CRONICAS cohort study and PERU MIGRANT study (n=2844)
| Variables | Low Short-Term/Low Lifetime Risk (n*=858, 353, 505) | Low Short-Term/High Lifetime Risk (n*=1007, 356, 651) | High Short-Term Risk (n*=979, 713, 266) |
|---|---|---|---|
| Age, y, mean (SD) | 50.9 (7.7) | 51.0 (6.9) | 65.3 (8.4) |
| Men | 49.6 (6.3) | 47.2 (5.0) | 63.4 (8.5) |
| Women | 51.8 (8.4) | 53.0 (6.9) | 70.3 (5.6) |
| SBP, mm Hg, mean (SD) | 109.7 (11.7) | 116.8 (16.6) | 130.1 (20.6) |
| Men | 114.4 (10.0) | 120.9 (15.1) | 128.8 (19.5) |
| Women | 106.5 (11.7) | 114.5 (16.9) | 133.6 (22.9) |
| DBP, mm Hg, mean (SD) | 69.6 (8.0) | 73.9 (10.8) | 77.2 (12.0) |
| Men | 71.7 (7.7) | 76.7 (10.2) | 77.8 (11.7) |
| Women | 68.1 (8.0) | 72.4 (10.8) | 75.7 (12.4) |
| BMI, kg/m2, mean (SD) | 26.4 (4.4) | 28.9 (4.9) | 27.2 (4.4) |
| Men | 25.5 (3.5) | 27.3 (3.8) | 27.1 (4.1) |
| Women | 27.1 (4.8) | 29.7 (5.3) | 27.6 (4.9) |
| Waist circumference, cm, mean (SD) | 87.2 (11.2) | 93.1 (10.9) | 93.0 (11.1) |
| Men | 88.6 (9.7) | 93.1 (9.4) | 94.0 (10.5) |
| Women | 86.3 (12.0) | 93.1 (11.6) | 90.5 (12.2) |
| Total cholesterol, mg/dL, mean (SD) | 169.1 (22.5) | 220.9 (35.6) | 202.9 (41.0) |
| Men | 166.3 (23.0) | 210.6 (34.7) | 201.2 (40.6) |
| Women | 171.0 (21.9) | 226.4 (34.8) | 207.5 (41.7) |
| HDL-C, mg/dL, mean (SD) | 41.5 (11.2) | 43.5 (11.6) | 40.5 (11.2) |
| Men | 40.3 (11.1) | 42.5 (11.9) | 39.5 (10.5) |
| Women | 42.4 (11.2) | 44.1 (11.5) | 43.2 (12.4) |
| Triglycerides, mg/dL, mean (SD) | 131.5 (71.2) | 178.9 (104.1) | 173.3 (111.1) |
| Men | 134.7 (84.1) | 175.9 (110.6) | 171.8 (107.5) |
| Women | 129.3 (60.7) | 180.6 (100.4) | 177.5 (120.4) |
| Total cholesterol/HDL, mean (SD) | 4.1 (1.1) | 5.0 (1.4) | 5.0 (1.6) |
| Men | 4.0 (1.1) | 4.7 (1.5) | 5.1 (1.5) |
| Women | 4.1 (1.1) | 5.1 (1.4) | 4.7 (2.2) |
| Current tobacco use, n (%) | 0 (0.0) | 123 (12.2) | 163 (16.7) |
| Men | 0 (0.0) | 88 (24.7) | 151 (21.2) |
| Women | 0 (0.0) | 35 (5.4) | 12 (4.5) |
| Diabetes, n (%) | 0 (0.0) | 84 (8.3) | 136 (13.9) |
| Men | 0 (0.0) | 13 (3.7) | 88 (12.3) |
| Women | 0 (0.0) | 71 (10.9) | 48 (18.1) |
| Hypertension, n (%) | 0 (0.0) | 233 (19.9) | 309 (37.9) |
| Men | 0 (0.0) | 96 (18.9) | 179 (31.9) |
| Women | 0 (0.0) | 137 (20.7) | 130 (51.2) |
| Dyslipidemia, n (%) | 576 (67.1) | 924 (91.8) | 814 (83.2) |
| Men | 185 (52.4) | 297 (83.4) | 574 (80.5) |
| Women | 391 (77.4) | 627 (96.3) | 240 (90.2) |
| Antihypertensive therapy, n (%) | 0 (0.0) | 77 (7.7) | 164 (16.8) |
| Men | 0 (0.0) | 7 (2.0) | 72 (10.1) |
| Women | 0 (0.0) | 70 (10.8) | 92 (34.6) |
| Pooled Cohort Risk Equations, % (mean, SD) | 2.4 (1.9) | 3.4 (1.9) | 17.0 (9.7) |
| Men | 3.3 (2.0) | 4.3 (1.8) | 17.6 (10.1) |
| Women | 1.8 (1.6) | 2.9 (1.8) | 15.5 (8.1) |
Dyslipidemia: TC ≥200 mg/dL or HDL-C <50 mg/dL (women), HDL-C <40 mg/dL (men). Hypertension: SBP ≥140 mm Hg, or DBP ≥90 mm Hg, or diagnosed by physician or taking antihypertensive medications. Diabetes: fasting glucose ≥126 mg/dL or taking diabetes medication. BMI indicates body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL-C, high-density lipoprotein cholesterol.
*1
n for total, men, and women.